PROTEIN-KINASES IN HUMAN BREAST-CANCER

被引:58
作者
CANCE, WG
LIU, ET
机构
[1] UNIV N CAROLINA, SCH MED, DEPT MED, CHAPEL HILL, NC 27599 USA
[2] UNIV N CAROLINA, SCH MED, DEPT EPIDEMIOL, CHAPEL HILL, NC 27599 USA
[3] UNIV N CAROLINA, SCH MED, LINEBERGER CANC RES CTR, PROGRAM GENET & MOLEC BIOL, CHAPEL HILL, NC 27599 USA
关键词
BREAST CANCER; FOCAL ADHESION KINASE; HER-2; NOVEL GENES; PROTEIN KINASES; TYROSINE KINASES;
D O I
10.1007/BF00694751
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The family of protein kinases includes many oncogenes and growth factor receptors, many of which have been linked to the pathogenesis and progression of cancer. Protein tyrosine kinases such as HER-2/c-erbB-2 and the epidermal growth factor receptor (EGFR) have been linked specifically to breast cancer, and perturbations of HER-2 affect response to chemotherapy. We have reviewed the biology of protein kinases in human breast cancer, as well as their translational applications to breast cancer patients. We have studied the spectrum of protein kinases expressed in human breast cancer cells and have identified four protein kinases with potentially important functions in breast cancer: rak (src-related), TK5 (which we now designate JAK3), the focal adhesion kinase (FAK), and STK1 (human MO15/CAK). We describe the potential significance of these genes in breast cancer, as well as our methodology for identifying and characterizing novel genes in breast cancer.
引用
收藏
页码:105 / 114
页数:10
相关论文
共 55 条
[21]  
KORNBERG L, 1992, J BIOL CHEM, V267, P23439
[22]  
LAMMIE GA, 1991, ONCOGENE, V6, P439
[23]   COMPLEMENTATION USED TO CLONE A HUMAN HOMOLOG OF THE FISSION YEAST-CELL CYCLE CONTROL GENE CDC2 [J].
LEE, MG ;
NURSE, P .
NATURE, 1987, 327 (6117) :31-35
[24]  
LETWIN K, 1988, ONCOGENE, V3, P621
[25]  
LEVEDAKOU EN, 1994, ONCOGENE, V9, P1977
[26]  
LIDEREAU R, 1988, ONCOGENE RES, V2, P285
[27]   CANCER METASTASIS AND ANGIOGENESIS - AN IMBALANCE OF POSITIVE AND NEGATIVE REGULATION [J].
LIOTTA, LA ;
STEEG, PS ;
STETLERSTEVENSON, WG .
CELL, 1991, 64 (02) :327-336
[28]  
LIU E, 1992, ONCOGENE, V7, P1027
[29]   THE PROTEIN-TYROSINE KINASE JAK1 COMPLEMENTS DEFECTS IN INTERFERON-ALPHA/BETA AND INTERFERON-GAMMA SIGNAL-TRANSDUCTION [J].
MULLER, M ;
BRISCOE, J ;
LAXTON, C ;
GUSCHIN, D ;
ZIEMIECKI, A ;
SILVENNOINEN, O ;
HARPUR, AG ;
BARBIERI, G ;
WITTHUHN, BA ;
SCHINDLER, C ;
PELLEGRINI, S ;
WILKS, AF ;
IHLE, JN ;
STARK, GR ;
KERR, IM .
NATURE, 1993, 366 (6451) :129-135
[30]   C-ERBB-2 EXPRESSION AND RESPONSE TO ADJUVANT THERAPY IN WOMEN WITH NODE-POSITIVE EARLY BREAST-CANCER [J].
MUSS, HB ;
THOR, AD ;
BERRY, DA ;
KUTE, T ;
LIU, ET ;
KOERNER, F ;
CIRRINCIONE, CT ;
BUDMAN, DR ;
WOOD, WC ;
BARCOS, M ;
HENDERSON, IC .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (18) :1260-1266